mRNA rose to global prominence during the COVID-19 pandemic. However, we believe mRNA’s most significant contribution is just beginning. At its core, messenger RNA (mRNA) technology is about sending precise biological instructions to the body; a concept perfectly aligned with our mission at BIOMED: delivering personalized, precision medicine built on the unique profiles of real
Continue Reading
At medibles, we believe the future of medicine is precise and personalized. Today, we’re excited to share a significant step forward in that vision. Medibles, the personalized health and wellness platform developed by BIOMED Inc., is proud to announce our participation in the National Institutes of Health’s (NIH) All of Us Research Program. This partnership
Continue Reading
Today, Los Angeles, February 10, 2023 /PRNewswire/ — BIOMED, the leading next-generation healthcare platform, was chosen as one of the top ten finalists for the MedTech Color 2023 Pitch Competition. MedTech Color (MTC) is a nonprofit organization that aims to advance the representation of persons of color in the Medtech industry. The 2023 chosen entries
Continue Reading
As we continue to navigate the evolving landscape of COVID-19, new data shows promising strides in protecting vulnerable populations, especially older adults, from serious outcomes. A recent study led by researchers at Brigham & Women’s Hospital reveals that Paxlovid, a combination antiviral treatment, significantly reduces the risk of hospitalization and death due to COVID-19 caused
Continue Reading
Cannabis legalization has been an enormous success with a significant economic impact. The new report from this Federal Reserve Bank district shows how cannabis-related businesses create jobs and generate tax revenue. An analysis was published last week by the Federal Reserve bank of Kansas City, which covers the 10th District of the Federal Reserve, which includes
Continue Reading
